Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
.comment
 |  |  |  |  | 


Opinion

Anticipating the $1,000 genome

Elaine R Mardis email

Genome Sequencing Center, Washington University School of Medicine, 4444 Forest Park Boulevard, St. Louis, MO 63108, USA

author email corresponding author email

Genome Biology 2006, 7:112doi:10.1186/gb-2006-7-7-112

Published: 27 July 2006

Subject areas: Genome studies, Bioinformatics, Methods, Medicine

Abstract

A new generation of DNA-sequencing platforms will become commercially available over the next few years. These instruments will enable re-sequencing of human genomes at a previously unimagined throughput and low cost. Here, I examine why the $1,000 human genome is an important goal for research and clinical diagnostics, and what will be required to achieve it.


© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.